Last reviewed · How we verify
The Aim of This Study is to Evaluate the Efficacy and Safety of the Investigational Device, SurgiShield Anti-Adhesion Barrier Gel Made by D Med
This clinical trial is intended to evaluate the impact, efficacy, and safety of Chitosan formulated adhesion inhibitor, SurgiShield when used in the process of wound healing after endoscopic sinus surgery.
Details
| Lead sponsor | D.med |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 33 |
| Start date | 2012-03 |
| Completion | 2013-04 |
Conditions
- Wound Healing
Interventions
- 5ml surgishield
Primary outcomes
- Adhesion Rate — at 2 weeks
Adhesion rate at 2 weeks after ESS(endoscopic sinus surgery)
Countries
South Korea